Assembly Biosciences, Inc. (ASMB) vs Contineum Therapeutics, Inc. (CTNM)
Assembly Biosciences, Inc. and Contineum Therapeutics, Inc. are both Biotechnology companies. Assembly Biosciences, Inc. and Contineum Therapeutics, Inc. are of similar size ($481.7M and $469.9M). Contineum Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Assembly Biosciences, Inc. trades at 23.2×. Contineum Therapeutics, Inc. has the higher net margin (0.00% vs −0.06%) and the lower return on invested capital (−1,334.4% vs 0.00%). Across the 12 metrics below, Assembly Biosciences, Inc. leads on 7 and Contineum Therapeutics, Inc. on 5.
Valuation
Profitability
| Metric | ASMB | CTNM | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | — | 65.16% |
| Operating margin | (11.75%) | 0.00% | 0.00% |
| Net margin | (0.06%) | 0.00% | 0.00% |
| Free cash flow margin | (51.53%) | 0.00% | 0.00% |
| Return on equity | (0.03%) | (28.01%) | (57.72%) |
| Return on assets | (0.02%) | (26.57%) | (49.22%) |
| Return on invested capital | 0.00% | (1,334.41%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack